p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

Cell

Volumn 74, Issue 6, 1993, Pages 957-967

  Lowe, Scott W ^a   Ruley, H Earl ^b   Jacks, Tyler ^a   Housman, David E ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; PROTEIN P53; SODIUM AZIDE;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; DNA DAMAGE; DNA METABOLISM; DRUG CYTOTOXICITY; DRUG RESISTANCE; DRUG SENSITIVITY; EMBRYO; FIBROBLAST; IONIZING RADIATION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

ADENOVIRUS E1A PROTEINS; ANIMAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; DNA; EMBRYO; FIBROBLASTS; FLOW CYTOMETRY; GENES, P53; GENES, RAS; GENOTYPE; MICE; ONCOGENES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION;

ADENOVIRIDAE; ANIMALIA;

EID: 0027451668     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(93)90719-7     Document Type: Article

References (62)

1. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia
2. Clinical pharmacology of cancer chemotherapy
3. Induction of E1A oncogene expression of cellular susceptibility to lysis by TNF
4. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer
5. Function and regulation of the human multidrug resistance gene
6. Thymocyte apoptosis induced by p53-dependent and independent pathways
7. Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens
8. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours
9. High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors
10. Relation between p53 overexpression and established prognostic factors in breast cancer
11. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B
12. Drug-target interactions: only the first step in the commitment to a programmed cell death?
13. Activation of programmed cell death by anticancer agents: cisplatin as a model system
14. Induction of apoptosis in fibroblasts by c-myc protein
15. Cooperative interaction between c-myc and bcl-2 proto-oncogenes
16. A genetic model for colorectal tumorigeneisis
17. Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia
18. Mammalian genes induced by radiation; activation of genes associated with growth control
19. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents
20. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia
21. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts
22. Timing and role of p53 gene mutation in the recurrence of glioma
23. No germline TP53 mutations detected in familial and bilateral testicular cancer
24. Response to adversity: molecular control of gene activation following genotoxic stress
25. p53 mutations in human cancers
26. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer
27. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles
28. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours
29. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia
30. Participation of p53 protein in the cellular response to DNA damage
31. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
32. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note
33. p53, guardian of the genome
34. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli
35. The p53 tumour suppressor gene
36. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
37. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells
38. Stabilization of the p53 tumor suppressor is induced by adenovirus E1A and accompanies apoptosis
39. p53 is required for radiation-induced apoptosis in mouse thymocytes
40. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
41. p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy
42. Amplification of a gene encoding a p53-associated protein in human sarcomas
43. Social controls on cell survival and cell death
44. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and Bcl-2 proteins
45. Transforming collaborations between ras and nuclear oncogenes
46. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
47. Apoptosis
48. Activation-induced cell death in T cell hybridomas is due to apoptosis
49. Clonal expansion of p53 mutant cells is associated with brain tumour progression
50. Identification of p53 gene mutations in bladder cancers and urine samples
51. Expression of mutant p53 in melanoma
52. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
53. p53: a frequent target for genetic abnormalities in lung cancer
54. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern
55. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor
56. A rapid flow cytometric method for bivariate bromodeoxyuridine/DNA analysis using simultaneous proteolytic enzyme digestion and acid denaturation
57. Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation
58. The SOS response of Escherichia coli
59. Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight antigen cause the degradation of chromosomal DNA
60. Adenovirus E1B 19-kilodalton protein overcomes the cytoxicity of E1A proteins
61. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
62. p53 mutation in acute lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines